Net Income Summary of Apex Biotechnology Corp.

Apex Biotechnology Corp.'s latest annual net income in 2023 was 115.78 Million TWD , down -36.31% from previous year.
Apex Biotechnology Corp.'s latest quarterly net income in 2024 Q2 was 27.28 Million TWD , down -6.36% from previous quarter.
Apex Biotechnology Corp. reported an annual net income of 181.78 Million TWD in 2022, down -10.11% from previous year.
Apex Biotechnology Corp. reported an annual net income of 202.22 Million TWD in 2021, up 113.33% from previous year.
Apex Biotechnology Corp. reported a quarterly net income of 29.14 Million TWD for 2024 Q1, up 92.14% from previous quarter.
Apex Biotechnology Corp. reported a quarterly net income of 15.16 Million TWD for 2023 Q4, down -59.94% from previous quarter.

Annual Net Income Chart of Apex Biotechnology Corp. (2023 - 2009)

Historical Annual Net Income of Apex Biotechnology Corp. (2023 - 2009)

Year	Net Income	Net Income Growth
2023	115.78 Million TWD	-36.31%
2022	181.78 Million TWD	-10.11%
2021	202.22 Million TWD	113.33%
2020	94.79 Million TWD	-16.74%
2019	113.85 Million TWD	19.7%
2018	95.11 Million TWD	11.18%
2017	85.55 Million TWD	2589.5%
2016	3.18 Million TWD	-98.79%
2015	261.85 Million TWD	-4.22%
2014	273.37 Million TWD	-26.36%
2013	371.22 Million TWD	-28.98%
2012	522.71 Million TWD	-0.74%
2011	526.61 Million TWD	16.01%
2010	453.94 Million TWD	39.04%
2009	326.48 Million TWD	0.0%

Year	Net Income	Net Income Growth
2024 Q2	27.28 Million TWD	-6.36%
2024 Q1	29.14 Million TWD	92.14%
2023 Q4	15.16 Million TWD	-59.94%
2023 Q2	27.01 Million TWD	-24.39%
2023 FY	115.78 Million TWD	-36.31%
2023 Q1	35.73 Million TWD	-17.15%
2023 Q3	37.86 Million TWD	40.13%
2022 Q3	64 Million TWD	120.23%
2022 FY	181.78 Million TWD	-10.11%
2022 Q1	45.59 Million TWD	-44.09%
2022 Q4	43.13 Million TWD	-32.61%
2022 Q2	29.06 Million TWD	-36.26%
2021 FY	202.22 Million TWD	113.33%
2021 Q3	64.04 Million TWD	185.0%
2021 Q1	34.16 Million TWD	3.65%
2021 Q4	81.55 Million TWD	27.34%
2021 Q2	22.47 Million TWD	-34.22%
2020 Q2	26.76 Million TWD	123.6%
2020 Q1	11.96 Million TWD	-85.19%
2020 Q4	32.95 Million TWD	42.61%
2020 FY	94.79 Million TWD	-16.74%
2020 Q3	23.11 Million TWD	-13.64%
2019 Q3	-16.61 Million TWD	-159.46%
2019 FY	113.85 Million TWD	19.7%
2019 Q1	21.73 Million TWD	158.47%
2019 Q2	27.94 Million TWD	28.57%
2019 Q4	80.79 Million TWD	586.16%
2018 Q2	44.81 Million TWD	162.7%
2018 FY	95.11 Million TWD	11.18%
2018 Q3	70.42 Million TWD	57.16%
2018 Q1	17.05 Million TWD	-61.84%
2018 Q4	-37.17 Million TWD	-152.79%
2017 Q4	44.7 Million TWD	102.23%
2017 Q1	-38.91 Million TWD	70.15%
2017 Q3	22.1 Million TWD	-61.67%
2017 FY	85.55 Million TWD	2589.5%
2017 Q2	57.66 Million TWD	248.17%
2016 Q4	-130.38 Million TWD	-10489.48%
2016 FY	3.18 Million TWD	-98.79%
2016 Q1	67.34 Million TWD	-10.55%
2016 Q2	64.97 Million TWD	-3.52%
2016 Q3	1.25 Million TWD	-98.07%
2015 Q3	108.88 Million TWD	166.36%
2015 FY	261.85 Million TWD	-4.22%
2015 Q1	36.79 Million TWD	-56.32%
2015 Q2	40.88 Million TWD	11.1%
2015 Q4	75.28 Million TWD	-30.86%
2014 Q1	62.26 Million TWD	104.62%
2014 Q4	84.23 Million TWD	34.8%
2014 Q3	62.48 Million TWD	-2.95%
2014 Q2	64.38 Million TWD	3.41%
2014 FY	273.37 Million TWD	-26.36%
2013 Q3	51.64 Million TWD	-68.34%
2013 Q4	30.43 Million TWD	-41.07%
2013 FY	371.22 Million TWD	-28.98%
2013 Q1	126.02 Million TWD	0.25%
2013 Q2	163.12 Million TWD	29.45%
2012 Q2	146.27 Million TWD	3.98%
2012 FY	522.71 Million TWD	-0.74%
2012 Q3	108.06 Million TWD	-26.12%
2012 Q1	140.67 Million TWD	-3.14%
2012 Q4	125.7 Million TWD	16.32%
2011 Q4	145.23 Million TWD	-16.55%
2011 Q1	96.98 Million TWD	7.0%
2011 Q3	174.03 Million TWD	57.69%
2011 FY	526.61 Million TWD	16.01%
2011 Q2	110.36 Million TWD	13.79%
2010 Q2	124.11 Million TWD	14.85%
2010 Q4	90.63 Million TWD	-30.88%
2010 Q1	108.06 Million TWD	0.0%
2010 FY	453.94 Million TWD	39.04%
2010 Q3	131.13 Million TWD	5.66%
2009 FY	326.48 Million TWD	0.0%

Peer Net Income Comparison of Apex Biotechnology Corp.

Name	Net Income	Net Income Difference
Sinphar Pharmaceutical Co.,Ltd.	375.17 Million TWD	69.139%
Panion & Bf Biotech Inc.	77.21 Million TWD	-49.941%
Chunghwa Chemical Synthesis & Biotech Co., Ltd.	264.9 Million TWD	56.293%
GenMont Biotech Incorporation	32.99 Million TWD	-250.953%
Abnova (Taiwan) Corporation	43.67 Million TWD	-165.083%
Adimmune Corporation	-639.89 Million TWD	118.094%
Tanvex BioPharma, Inc.	-2.13 Billion TWD	105.418%
Polaris Group	-1.57 Billion TWD	107.343%
Energenesis Biomedical CO.,LTD.	-260.38 Million TWD	144.467%
UnicoCell Biomed Co., Ltd.	-84.1 Million TWD	237.66%
PELL Bio-Med Technology Co. Ltd.	-398.75 Million TWD	129.036%

Global Stocks Search

Apex Biotechnology Corp. (1733.TW)

Net Income Summary of Apex Biotechnology Corp.

Annual Net Income Chart of Apex Biotechnology Corp. (2023 - 2009)

Historical Annual Net Income of Apex Biotechnology Corp. (2023 - 2009)

Peer Net Income Comparison of Apex Biotechnology Corp.